RAC 3.31% $1.61 race oncology ltd

General Comments / Chat, page-7593

  1. 2,703 Posts.
    lightbulb Created with Sketch. 2822
    the strategy was a clear focus on getting the drug to approval. The focus on investors atm is not a priority at present IMO as they are fully funded for current programs. So SP is going to dictated by the market in the meantime, based on previous announcements. Enjoy the roller coaster!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.